Skip to main content
Back
Watch Compare

HARVARD BIOSCIENCE INC

Data quality: 100%
HBIO
Nasdaq Manufacturing Measuring & Analyzing Instruments
$5.38
▼ $0.17 (-3.06%)
Mkt Cap: 24.06 M
Price
$5.38
Mkt Cap
24.06 M
Day Range
$5.37 — $5.55
52-Week Range
$2.80 — $9.50
Volume
21,191
Open $5.55
50D / 200D Avg
$5.39
0.16% below
50D / 200D Avg
$5.40
0.30% below

Quick Summary

Key Takeaways

Revenue declined -7.63% annually over 5 years
Debt/Equity of 2.41 — high leverage
Generating 5.47 M in free cash flow
Capital efficient — spends only 1.45% of revenue on capex

Growth

Revenue Growth (5Y)
-7.63%
Below sector avg (1.82%)
Revenue (1Y)-8.06%
Earnings (1Y)N/A
FCF Growth (3Y)-33.14%

Quality

Return on Equity
-380.52%
Below sector avg (-53.41%)
ROIC-158.30%
Net Margin-65.51%
Op. Margin-56.13%

Safety

Debt / Equity
2.41
Above sector avg (0.31)
Current Ratio0.81
Interest Coverage-13.49

Valuation

PE (TTM)
-0.42
Above sector avg (-1.48)
P/B Ratio1.71
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.4 -1.5
P/B 1.7 1.6
ROE % -380.5 -53.4
Net Margin % -65.5 -41.5
Rev Growth 5Y % -7.6 1.8
D/E 2.4 0.3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8.06% Revenue Growth (3Y) -12.19%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -7.63% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 86.55 M Net Income (TTM) -56.70 M
ROE -380.52% ROA -71.73%
Gross Margin 57.67% Operating Margin -56.13%
Net Margin -65.51% Free Cash Flow (TTM) 5.47 M
ROIC -158.30% FCF Growth (3Y) -33.14%
Safety
Debt / Equity 2.41 Current Ratio 0.81
Interest Coverage -13.49 Asset Turnover 1.10
Working Capital -10.59 M Tangible Book Value -3.84 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.42 Forward P/E N/A
P/B Ratio 1.71 P/S Ratio 0.28
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 22.74%
Market Cap 24.06 M Enterprise Value 51.21 M
Per Share
EPS (Diluted TTM) -1.28 Revenue / Share 19.35
FCF / Share 1.22 OCF / Share 1.50
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.45% FCF Conversion -9.65%
SBC-Adj. FCF 3.02 M Growth Momentum -0.43

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 86.55 M 94.14 M 112.25 M 113.34 M 118.90 M
Net Income -56.70 M -12.41 M -3.42 M -9.52 M -288,000.0
EPS (Diluted) -1.28 -0.28 -0.08 — —
Gross Profit 49.91 M 54.77 M 66.07 M 60.82 M 67.65 M
Operating Income -48.58 M -6.21 M 1.89 M -6.93 M 2.07 M
EBITDA — — — — —
R&D Expenses 8.83 M 10.41 M 11.76 M 12.33 M 10.80 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 3.60 M — — — —
Income Tax -686,000.0 740,000.0 859,000.0 337,000.0 148,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 80.07 M 126.64 M 137.37 M 145.36 M 162.34 M
Total Liabilities 66.34 M 63.30 M 64.29 M 73.14 M 78.94 M
Shareholders' Equity 13.73 M 63.34 M 73.07 M 72.22 M 83.40 M
Total Debt 35.87 M 36.96 M 36.56 M 46.82 M 48.33 M
Cash & Equivalents 8.61 M 4.11 M 4.28 M 4.51 M 7.82 M
Current Assets 48.23 M 45.12 M 49.04 M 51.12 M 61.58 M
Current Liabilities 21.96 M 54.96 M 26.54 M 23.25 M 25.32 M